The FDA Approves New Treatment For Devastating Disease And It Will Cost A Fortune

Credit: Wochit News
Published on May 24, 2019 - Duration: 00:49s

The FDA Approves New Treatment For Devastating Disease And It Will Cost A Fortune

The US FDA just approved a new treatment for a devastating rare genetic disease.

Called Zolgensma, it is a type of cutting-edge, one-time treatment called a "gene therapy" that treats the disease spinal muscular atrophy at its genetic root.

That means it should work longer than the typical drug, but has also translated to a much higher price tag, too.

Zolgensma, which is made by drugmaker Novartis's AveXis unit, will cost $2.125 million, the company said on Friday.

Advertisement

The FDA Approves New Treatment For Devastating Disease And It Will Cost A Fortune

AP FILE PHOTO OF AUG.

13, 2016 OCT.

14, 2015, FILE PHOTO

You are here

Recent related videos from verified sources

Study: Kratom Linked To Serious, Life-Threatening Side Effects 00:50
Credit: Wochit News - Published 2 weeks ago 

In Landmark Trial, Experimental Drug Delays Type 1 Diabetes 00:35
Credit: Wochit News - Published on June 9, 2019 

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction 04:16
Credit: The Street - Published on June 5, 2019 

FDA Approves Most Expensive Drug In History 00:37
Credit: Wochit News - Published on May 24, 2019 

You might like